Enquiry form for progressive Multiple Sclerosis (MS)

24-502 Part B – people with progressive MS

Participants with progressive multiple sclerosis (MS) needed for the study of a potential new medicine to treat MS and idiopathic pulmonary fibrosis (IPF). You must be aged 25 to 65, with a BMI between 18 and 30.9. Women must be post-menopausal for at least 1 year or surgically sterilised. This study involves 2 screening visits (including 1 MRI scan), up to 6 nights’ residence on our ward and 2 outpatient visits. You’ll have a total of 3 PET scans. Starts 24 February 2025.

Receive up to £4,865 + reasonable travel expenses.

This form is for people with progressive MS. By participating in one of our trials, you’ll be helping to advance medical research and improve human health.